AbbVie banal jumped aboriginal Friday aft the pharmaceutical institution reported adjusted income of $3.33 per stock connected $14.34 cardinal successful third-quarter sales.
X
On average, analysts polled by FactSet expected AbbVie (ABBV) to gain $3.21 per stock connected $14.3 cardinal successful sales. Among its segments, AbbVie's aesthetics portfolio — which includes skin-smoothing injection Botox — posted the biggest growth, up 29.3%. Major moneymaker, inflammatory med Humira, generated $5.43 cardinal globally.
In the year-earlier period, AbbVie net were $2.83 a stock and the institution reported $12.9 cardinal successful sales.
For the year, AbbVie guided to adjusted nett of $12.63-$12.67 per share. AbbVie banal analysts expected net of $12.59 per stock and $56.2 cardinal successful sales.
In premarket trading connected today's banal market, AbbVie banal roseate 2.6% adjacent 112.60. AbbVie banal is forming a flat base with a buy point astatine 121.63, according to MarketSmith.com.
More to follow.
Follow Allison Gatlin connected Twitter astatine @IBD_AGatlin.
YOU MAY ALSO LIKE:
Alnylam Stock Dives As Sales Growth Falters And CEO John Maraganore Plans Exit
How Merck's Antiviral Covid Pill Could Add To Its Already Bullish 2021 Outlook
Get Timely Buy & Sell Alerts With IBD Leaderboard
How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks
Options Trading: How To Start Using Options, How To Manage Risk
English (US) ·